These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26431682)

  • 1. Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats.
    Williams KE; Washington MC; Johnson-Rouse T; Johnson RE; Freeman C; Reed C; Heath J; Sayegh AI
    Appetite; 2016 Jan; 96():254-259. PubMed ID: 26431682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiac and the cranial mesenteric arteries supply gastrointestinal sites that regulate meal size and intermeal interval length via cholecystokinin-58 in male rats.
    Sayegh AI; Washington MC; Johnson RE; Johnson-Rouse T; Freeman C; Harrison A; Lucas J; Shelby M; Fisher B; Willis W; Reeve JJ
    Horm Behav; 2015 Jan; 67():48-53. PubMed ID: 25479193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stomach and/or upper duodenum contain sites of action that control meal size and intermeal interval length by exogenous rat gastrin releasing peptide.
    Washington MC; Aglan AH; Sayegh AI
    Peptides; 2014 May; 55():41-6. PubMed ID: 24556509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feeding responses evoked by endogenous cholecystokinin are regulated by different gastrointestinal sites.
    Washington MC; Williams K; Sayegh AI
    Horm Behav; 2016 Feb; 78():79-85. PubMed ID: 26522495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats.
    Washington MC; Mhalhal TR; Sayegh AI
    Horm Behav; 2016 Sep; 85():36-42. PubMed ID: 27497934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats.
    Mhalhal TR; Washington MC; Newman K; Heath JC; Sayegh AI
    Physiol Behav; 2017 Oct; 179():191-199. PubMed ID: 28647503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29.
    Washington MC; Mhalhal TR; Sayegh AI
    Horm Behav; 2016 Sep; 85():1-4. PubMed ID: 27381650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass augments the feeding responses evoked by gastrin-releasing peptides.
    Washington MC; Mhalhal TR; Johnson-Rouse T; Berger J; Heath J; Seeley R; Sayegh AI
    J Surg Res; 2016 Dec; 206(2):517-524. PubMed ID: 27884350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
    Rüttimann EB; Arnold M; Hillebrand JJ; Geary N; Langhans W
    Endocrinology; 2009 Mar; 150(3):1174-81. PubMed ID: 18948395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats.
    Rüttimann EB; Arnold M; Geary N; Langhans W
    Physiol Behav; 2010 Jun; 100(4):291-6. PubMed ID: 20206193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.
    Baumgartner I; Pacheco-López G; Rüttimann EB; Arnold M; Asarian L; Langhans W; Geary N; Hillebrand JJ
    J Neuroendocrinol; 2010 Jun; 22(6):557-63. PubMed ID: 20298455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined gastrin releasing peptide-29 and glucagon like peptide-1 reduce body weight more than each individual peptide in diet-induced obese male rats.
    Mhalhal TR; Washington MC; Newman KD; Heath JC; Sayegh AI
    Neuropeptides; 2018 Feb; 67():71-78. PubMed ID: 29180139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
    Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.
    Anderberg RH; Richard JE; Hansson C; Nissbrandt H; Bergquist F; Skibicka KP
    Psychoneuroendocrinology; 2016 Mar; 65():54-66. PubMed ID: 26724568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Vagotomy and Sympathectomy on the Feeding Responses Evoked by Intra-Aortic Cholecystokinin-8 in Adult Male Sprague Dawley Rats.
    Mhalhal TR; Washington MC; Heath JC; Sayegh AI
    Endocr Res; 2021; 46(2):57-65. PubMed ID: 33426974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral glucagon-like peptide-1 (GLP-1) and satiation.
    Punjabi M; Arnold M; Geary N; Langhans W; Pacheco-López G
    Physiol Behav; 2011 Nov; 105(1):71-6. PubMed ID: 21371486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance.
    Reiner DJ; Leon RM; McGrath LE; Koch-Laskowski K; Hahn JD; Kanoski SE; Mietlicki-Baase EG; Hayes MR
    Neuropsychopharmacology; 2018 Feb; 43(3):627-637. PubMed ID: 28920591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission.
    Hsu TM; Hahn JD; Konanur VR; Lam A; Kanoski SE
    Neuropsychopharmacology; 2015 Jan; 40(2):327-37. PubMed ID: 25035078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
    Vahl TP; Tauchi M; Durler TS; Elfers EE; Fernandes TM; Bitner RD; Ellis KS; Woods SC; Seeley RJ; Herman JP; D'Alessio DA
    Endocrinology; 2007 Oct; 148(10):4965-73. PubMed ID: 17584962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval.
    Washington MC; Coggeshall J; Sayegh AI
    Peptides; 2011 May; 32(5):971-7. PubMed ID: 21335043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.